ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for calcium acetate ...
Perrigo announced that it has received final approval from the FDA for Calcium acetate capsules, the generic version of Fresenius Medical Care NA‘s Phoslo (calcium acetate 667mg [elemental calcium ...
Perrigo announced that it has received final approval from the FDA for its abbreviated new drug application for calcium acetate capsules, the generic equivalent of Phoslo Gelcaps. Perrigo was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results